Praxis Over Delivers, Under Budget with Brand Extension
Praxis recently provided recruitment services to a pharmaceutical company for a study to test a medication for a women’s health indication. This was the third successful brand extension for their client. In this latest campaign execution, specific social media tactics were included to help drive the 1365% ROI the sponsor realized. This latest recruitment program over-delivered on patients by 73% for two thirds the planned recruitment investment.
According to David Fox, President and CEO of Praxis “As we continue to support and partner with this sponsor each step builds upon the previous. Our initial brand building efforts and up-front planning pay dividends with heightened awareness among our patient population. All of this adds up to saved money and time for the sponsor."
The study was centrally managed and patient recruitment results were available in real-time, 24/7 using PraxisDirect®, Praxis’ online study management technology. PraxisDirect also played a role in the daily life of the study coordinator by offering key assistance and tracking regarding patient outcomes.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
